O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer

Carcinogenesis

Volumn 34, Issue 11, 2013, Pages 2435-2442

  Fahrer, Jörg ^a   Kaina, Bernd ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; MESALAZINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NITROSO DERIVATIVE; NITROSOUREA; PROCARBAZINE; TEMOZOLOMIDE;

ALKYLATION; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DNA ALKYLATION; GENE MUTATION; HUMAN; METASTASIS; MUTAGENIC ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; ANIMAL; COLORECTAL TUMOR; GENETICS; PROGNOSIS; COLORECTAL NEOPLASMS;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; NITROSO COMPOUNDS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROGNOSIS;

EID: 84887004374     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt275     Document Type: Review

References (123)

1. Cunningham,D. et al. (2010) Colorectal cancer. Lancet, 375, 1030-1047.
2. Lynch,H.T. et al. (2008) Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam. Cancer, 7, 27-39.
3. Jones,S. et al. (2002) Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-T:A mutations. Hum. Mol. Genet., 11, 2961-2967.
4. Goss,K.H. et al. (2000) Biology of the adenomatous polyposis coli tumor suppressor. J. Clin. Oncol., 18, 1967-1979.
5. Ullman,T.A. et al. (2011) Intestinal inflammation and cancer. Gastroenterology, 140, 1807-1816.
6. Doll,R. et al. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
7. Willett,W.C. (1995) Diet, nutrition, and avoidable cancer. Environ. Health Perspect., 103 (suppl. 8), 165-170.
8. Watson,A.J. et al. (2011) Colon cancer: a civilization disorder. Dig. Dis., 29, 222-228.
9. Sugimura,T. (2000) Nutrition and dietary carcinogens. Carcinogenesis, 21, 387-395.
10. Santarelli,R.L. et al. (2008) Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr. Cancer, 60, 131-144.
11. Lijinsky,W. (1999) N-Nitroso compounds in the diet. Mutat. Res., 443, 129-138.
12. Schothorst,R.C. et al. (2005) Determination of N-nitrosodiethanolamine in cosmetic products by LC-MS-MS. Anal. Bioanal. Chem., 381, 681-685.
13. Hecht,S.S. (2008) Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol., 21, 160-171.
14. Bolzán,A.D. et al. (2002) Genotoxicity of streptozotocin. Mutat. Res., 512, 121-134.
15. Lundberg,J.O. et al. (2013) Biology of nitrogen oxides in the gastrointestinal tract. Gut., 62, 616-629.
16. Bingham,S.A. et al. (1996) Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis, 17, 515-523.
17. Cross,A.J. et al. (2003) Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res., 63, 2358-2360.
18. Lunn,J.C. et al. (2007) The effect of haem in red and processed meat on the endogenous formation of N-nitroso compounds in the upper gastrointestinal tract. Carcinogenesis, 28, 685-690.
19. Pierre,F. et al. (2003) Meat and cancer: haemoglobin and haemin in a lowcalcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis, 24, 1683-1690.
20. Pierre,F. et al. (2004) Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J. Nutr., 134, 2711-2716.
21. Pierre,F. et al. (2008) Beef meat promotion of dimethylhydrazine-induced colorectal carcinogenesis biomarkers is suppressed by dietary calcium. Br. J. Nutr., 99, 1000-1006.
22. Kimura,H. et al. (1998) Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut, 42, 180-187.
23. Hussain,S.P. et al. (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res., 60, 3333-3337.
24. Masuda,M. et al. (2000) Formation of N-nitrosamines and N-nitramines by the reaction of secondary amines with peroxynitrite and other reactive nitrogen species: comparison with nitrotyrosine formation. Chem. Res. Toxicol., 13, 301-308.
25. Mirvish,S.S. et al. (2003) N-nitroso compounds in the gastrointestinal tract of rats and in the feces of mice with induced colitis or fed hot dogs or beef. Carcinogenesis, 24, 595-603.
26. Yang,C.S. et al. (1990) Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev., 22, 147-159.
27. Thörn,M. et al. (2005) Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br. J. Clin. Pharmacol., 60, 54-60.
28. Beranek,D.T. (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res., 231, 11-30.
29. Swann,P.F. (1990) Why do O6-alkylguanine and O4-alkylthymine miscode? The relationship between the structure of DNA containing O6-alkylguanine and O4-alkylthymine and the mutagenic properties of these bases. Mutat. Res., 233, 81-94.
30. Shuker,D.E. et al. (1997) Nitrosated glycine derivatives as a potential source of O6-methylguanine in DNA. Cancer Res., 57, 366-369.
31. Harrison,K.L. et al. (1999) Detection of concomitant formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine in DNA exposed to nitrosated glycine derivatives using a combined immunoaffinity/HPLC method. Chem. Res. Toxicol., 12, 106-111.
32. Lewin,M.H. et al. (2006) Red meat enhances the colonic formation of the DNA adduct O6-carboxymethyl guanine: implications for colorectal cancer risk. Cancer Res., 66, 1859-1865.
33. Fu,D. et al. (2012) Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer, 12, 104-120.
34. Chakravarti,D. et al. (1991) Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase. J. Biol. Chem., 266, 15710-15715.
35. Engelward,B.P. et al. (1993) Cloning and characterization of a mouse 3-methyladenine/7-methyl-guanine/3-methylguanine DNA glycosylase cDNA whose gene maps to chromosome 11. Carcinogenesis, 14, 175-181.
36. Engelward,B.P. et al. (1997) Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase. Proc. Natl Acad. Sci. USA, 94, 13087-13092.
37. Christmann,M. et al. (2003) Mechanisms of human DNA repair: an update. Toxicology, 193, 3-34.
38. Meira,L.B. et al. (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest., 118, 2516-2525.
39. Kurowski,M.A. et al. (2003) Phylogenomic identification of five new human homologs of the DNA repair enzyme AlkB. BMC Genomics, 4, 48.
40. Gerken,T. et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate- dependent nucleic acid demethylase. Science, 318, 1469-1472.
41. Duncan,T. et al. (2002) Reversal of DNA alkylation damage by two human dioxygenases. Proc. Natl Acad. Sci. USA, 99, 16660-16665.
42. Aas,P.A. et al. (2003) Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature, 421, 859-863.
43. Mishina,Y. et al. (2005) Direct repair of the exocyclic DNA adduct 1,N6-ethenoadenine by the DNA repair AlkB proteins. J. Am. Chem. Soc., 127, 14594-14595.
44. Trewick,S.C. et al. (2002) Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature, 419, 174-178.
45. Calvo,J.A. et al. (2012) DNA repair is indispensable for survival after acute inflammation. J. Clin. Invest., 122, 2680-2689.
46. Kaina,B. et al. (2007) MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst.), 6, 1079-1099.
47. Srivenugopal,K.S. et al. (1996) Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2- chloroethyl)-1-nitrosourea. Biochemistry, 35, 1328-1334.
48. Xu-Welliver,M. et al. (2002) Degradation of the alkylated form of the DNA repair protein, O(6)-alkylguanine-DNA alkyltransferase. Carcinogenesis, 23, 823-830.
49. Dolan,M.E. et al. (1990) Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl Acad. Sci. USA, 87, 5368-5372.
50. Preuss,I. et al. (1996) Protective effect of O6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer, 65, 506-512.
51. Wang,L. et al. (1997) Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl) butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1- butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol., 10, 562-567.
52. Mijal,R.S. et al. (2004) The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by O6-alkylguanine- DNA alkyltransferase variants. Chem. Res. Toxicol., 17, 424-434.
53. Christmann,M. et al. (2012) O(6)-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smoke. Mutat. Res., 736, 64-74.
54. Senthong,P. et al. (2013) The nitrosated bile acid DNA lesion O6-carboxymethylguanine is a substrate for the human DNA repair protein O6-methylguanine-DNA methyltransferase. Nucleic Acids Res., 41, 3047-3055.
55. O'Driscoll,M. et al. (1999) The cytotoxicity of DNA carboxymethylation and methylation by the model carboxymethylating agent azaserine in human cells. Carcinogenesis, 20, 1855-1862.
56. Cupid,B.C. et al. (2004) Detection of O6-carboxymethyl-2'- deoxyguanosine in DNA following reaction of nitric oxide with glycine and in human blood DNA using a quantitative immunoslot blot assay. Chem. Res. Toxicol., 17, 294-300.
57. Kaina,B. et al. (1991) Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents. Carcinogenesis, 12, 1857-1867.
58. Becker,K. et al. (1996) Targeted expression of human O(6)-methylguanine- DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis. Cancer Res., 56, 3244-3249.
59. Duckett,D.R. et al. (1996) Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin- d(GpG) adduct. Proc. Natl Acad. Sci. USA, 93, 6443-6447.
60. Ochs,K. et al. (2000) Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res., 60, 5815-5824.
61. Mojas,N. et al. (2007) Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev., 21, 3342-3355.
62. Roos,W.P. et al. (2009) Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs. DNA Repair (Amst.), 8, 72-86.
63. Quiros,S. et al. (2010) Processing of O6-methylguanine into DNA doublestrand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle, 9, 168-178.
64. Yoshioka,K. et al. (2006) ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol. Cell, 22, 501-510.
65. Branch,P. et al. (1993) Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature, 362, 652-654.
66. Andrew,S.E. et al. (1998) Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent. Proc. Natl Acad. Sci. USA, 95, 1126-1130.
67. Kawate,H. et al. (1998) Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes. Proc. Natl Acad. Sci. USA, 95, 5116-5120.
68. Gottschalg,E. et al. (2007) Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl- 2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer. Carcinogenesis, 28, 356-362.
69. Zhang,F. et al. (2013) Structures of DNA duplexes containing O6-carboxymethylguanine, a lesion associated with gastrointestinal cancer, reveal a mechanism for inducing pyrimidine transition mutations. Nucleic Acids Res., 41, 5524-5532.
70. Dumenco,L.L. et al. (1993) The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase. Science, 259, 219-222.
71. Tsuzuki,T. et al. (1996) Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent. Carcinogenesis, 17, 1215-1220.
72. Glassner,B.J. et al. (1999) DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis, 14, 339-347.
73. Sakumi,K. et al. (1997) Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res., 57, 2415-2418.
74. Becker,K. et al. (2003) DNA repair protein MGMT protects against N-methyl-N-nitrosourea-induced conversion of benign into malignant tumors. Carcinogenesis, 24, 541-546.
75. Zaidi,N.H. et al. (1995) Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis, 16, 451-456.
76. Wali,R.K. et al. (1999) Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats. Carcinogenesis, 20, 2355-2360.
77. Tanaka,T. et al. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci., 94, 965-973.
78. Neufert,C. et al. (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc., 2, 1998-2004.
79. Fiala,E.S. (1977) Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer, 40, 2436-2445.
80. Wirtz,S. et al. (2007) Chemically induced mouse models of intestinal inflammation. Nat. Protoc., 2, 541-546.
81. Vivona,A.A. et al. (1993) K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis, 14, 1777-1781.
82. Takahashi,M. et al. (2000) Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis, 21, 1117-1120.
83. Becker,C. et al. (2005) In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut, 54, 950-954.
84. Wirtz,S. et al. (2010) Both base excision repair and O6-methylguanine- DNA methyltransferase protect against methylation-induced colon carcinogenesis. Carcinogenesis, 31, 2111-2117.
85. Bugni,J.M. et al. (2009) Alkylation-induced colon tumorigenesis in mice deficient in the Mgmt and Msh6 proteins. Oncogene, 28, 734-741.
86. Lees,N.P. et al. (2002) Longitudinal variation in O(6)-alkylguanine DNAalkyltransferase activity in the human colon and rectum. Br. J. Cancer, 87, 168-170.
87. Povey,A.C. et al. (2000) Determinants of O(6)-alkylguanine-DNA alkyltransferase activity in normal and tumour tissue from human colon and rectum. Int. J. Cancer, 85, 68-72.
88. Povey,A.C. et al. (2000) Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel. Gut, 47, 362-365.
89. Lees,N.P. et al. (2002) Heterogeneity of O(6)-alkylguanine-DNA alkyltransferase activity in colorectal cancer: implications for treatment. Oncology, 63, 393-397.
90. Herfarth,K.K. et al. (1999) A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol. Carcinog., 24, 90-98.
91. Lind,G.E. et al. (2004) A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol. Cancer, 3, 28.
92. Mikami,T. et al. (2007) Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors. Am. J. Clin. Pathol., 127, 366-373.
93. Matsumura,S. et al. (2003) The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis. Virchows Arch., 443, 518-523.
94. Chan,A.O. et al. (2002) CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol., 160, 1823-1830.
95. Nagasaka,T. et al. (2008) Methylation pattern of the O6-methylguanine- DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int. J. Cancer, 122, 2429-2436.
96. Esteller,M. et al. (2000) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res., 60, 2368-2371.
97. de Vogel,S. et al. (2009) MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann. Oncol., 20, 1216-1222.
98. Lees,N.P. et al. (2004) Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC-AT transition mutations in a population exposed to methylating agents. Carcinogenesis, 25, 1243-1247.
99. Jackson,P.E. et al. (1997) Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-AT transition in the K-ras oncogene. Carcinogenesis, 18, 1299-1302.
100. Shen,L. et al. (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J. Natl Cancer Inst., 97, 1330-1338.
101. Svrcek,M. et al. (2010) Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers. Gut, 59, 1516-1526.
102. Esteller,M. et al. (2001) Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res., 61, 4689-4692.
103. Baker,S.J. et al. (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722.
104. Fox,E.J. et al. (2006) Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. J. Mol. Diagn., 8, 68-75.
105. Weisenberger,D.J. et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet., 38, 787-793.
106. Ogino,S. et al. (2006) CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut, 55, 1000-1006.
107. Krehl,S. et al. (2012) Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis, 33, 620-628.
108. Lai,C.S. et al. (2011) Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol. Nutr. Food Res., 55, 1819-1828.
109. Tian,Y. et al. (2013) Chemopreventive effect of dietary glutamine on colitisassociated colon tumorigenesis in mice. Carcinogenesis, 34, 1593-1600.
110. Clapper,M.L. et al. (2008) 5-Aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis. Inflamm. Bowel Dis., 14, 1341-1347.
111. Rousseaux,C. et al. (2013) The 5-aminosalicylic acid anti-neoplastic effect in the intestine is mediated by PPARgamma. Carcinogenesis. 7 August, Epub ahead of print.
112. Huber,W.W. et al. (2003) Coffee and its chemopreventive components kahweol and cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver-comparison with phase II xenobiotic metabolism. Mutat. Res., 522, 57-68.
113. Niture,S.K. et al. (2007) Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis, 28, 378-389.
114. Christmann,M. et al. (2011) O(6)-methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. Biochim. Biophys. Acta, 1816, 179-190.
115. Markowitz,S.D. et al. (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med., 361, 2449-2460.
116. Içli,F. et al. (1999) Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil. Oncology, 56, 297-300.
117. Akbulut,H. et al. (2004) Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma. Exp. Oncol., 26, 149-152.
118. Khan,O.A. et al. (2008) A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. Br. J. Cancer, 98, 1614-1618.
119. Kaina,B. et al. (2010) Targeting O(6)-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy. Cell. Mol. Life Sci., 67, 3663-3681.
120. Von Hoff,D.D. et al. (2010) Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers. J. Clin. Oncol., 28, 4877-4883.
121. Shacham-Shmueli,E. et al. (2011) Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine? J. Clin. Oncol., 29, e262-e265.
122. Amatu,A. et al. (2013) Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer. Clin. Cancer Res., 19, 2265-2272.
123. Fearon,E.R. et al. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.